Latest filing published 02 Sept 2026 for 한스바이오메드.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Kb자산운용: trading record in brief
This profile gathers the share dealings of Kb자산운용 in 한스바이오메드. Over a trading history stretching from 5 December 2025 to 2 September 2026, the count stands at 5 filings.
In open-market terms, that means 3 purchases on one side and 1 sale on the other. The totals do not cover 4 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2026: 2 purchases and 1 sale on the market.
None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 2 September 2026, reports a transaction in 한스바이오메드. The last insider purchase was made public on 3 March 2026, 250 days ago. Filings reach the DART (FSS) feed a median of 13 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kb자산운용
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 0DART
- 191,407 sharesKRXDART:20260702000463
- 358,820 sharesKRXDART:20260303002909Canonical exit: 6 May 2026 (T+90)
- 185,942 sharesKRXDART:20260105000390Canonical exit: 23 Mar 2026 (T+90)
- 744,847 sharesKRXDART:20251211000214Canonical exit: 5 Mar 2026 (T+90)
5 of 5 declarations